News
Filters
Showing 1 - 10 out of 15 results
News
St. Louis Children’s Hospital Ranked No. 1 in Pediatrics in Missouri and St. Louis by U.S. News & World Report
ST. LOUIS (October 7, 2025) — U.S. News & World Report has again recognized St. Louis Children’s Hospital and its physician partners at WashU Medicine among America’s Best Children’s Hospitals, ranking St. Louis Children’s No. 1 in Missouri, No. 1 in St. Louis, and No. 3 in the Midwest region.
News
Barnes-Jewish Hospital Unveils State-of-the-Art Patient Care Tower
ST. LOUIS (September 18, 2025) – Plaza West Tower, the new 16-story patient care tower at Barnes-Jewish Hospital, will welcome patients beginning in October. The tower will provide private rooms for heart and vascular patients, advanced imaging, and the latest in surgical preparation and recovery. Plaza West Tower is designed to enhance the experience for patients and their families under the expert care of WashU Medicine physicians and BJC HealthCare clinical teams.
News
Strokes During Commute Turned MoBap Provider Into Grateful Patient
Article
How to Make Prepping for a Mammogram a Little Bit Easier
Article
7 Surprising Symptoms of Asthma
Asthma, a chronic condition that affects the airways in the lungs, can lead to a range of symptoms that interfere with daily life. While most people are familiar with the most common symptoms of asthma such as wheezing or whistling sounds, shortness of breath, chest tightness and frequent coughing, several others are not as widely recognized.
Article
Snot 101: Why Does Your Snot Change Colors — and How You Can Get Rid of It
Like clockwork, two times a year — cold and flu season and allergy season — we get a tingle in our sinuses that can only mean one thing: The snot floodgates are about to open.
Article
How to Stay Active, Safe, and Motivated to Exercise This Winter
Article
Are Mammograms Effective? Debunking Myths About Diagnosing Breast Cancer
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Article